Protara Therapeutics, Inc. (NASDAQ: TARA)

$5.33 +0.16 (+3.09%)
As of Apr 30, 2026 04:00 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001359931
P/E -3.78
Add ratio to table...

About

Protara Therapeutics, Inc. focuses on the development of biopharmaceuticals, specifically targeting rare diseases and conditions with significant unmet medical needs. The company operates within the biotechnology sector, leveraging its expertise in drug development to create innovative therapies aimed at improving patient outcomes. Protara Therapeutics' approach involves the use of proprietary technologies and platforms to advance its pipeline of therapeutic candidates through various stages of clinical development. The company generates revenue...

Read more

Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 109.90 Bn 27.78 9.16 -
2 REGN Regeneron Pharmaceuticals, Inc. 76.53 Bn 16.96 5.34 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 39.60 Bn 143.93 12.57 -
4 RVMD Revolution Medicines, Inc. 27.52 Bn -24.37 33,158.07 -
5 ZLAB Zai Lab Ltd 24.25 Bn -138.37 100.02 0.20 Bn
6 MESO Mesoblast Ltd 22.87 Bn -179.20 1,330.04 0.12 Bn
7 RPRX Royalty Pharma plc 21.29 Bn 27.68 8.95 8.95 Bn
8 ROIV Roivant Sciences Ltd. 19.34 Bn -31.53 3,368.96 -